Stockreport

Lipella Pharmaceuticals Announces Positive Final Results from Phase 2a Study of LP-10 in Oral Lichen Planus

Lipella Pharmaceuticals Inc.  (LIPO) 
PDF All 27 patients completed treatment with no serious adverse events, underscoring a favorable safety profileStatistically significant improvements achieved across all eff [Read more]